Medicina preventiva y salud pública
Especialidad
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biogipuzkoa (4)
2022
-
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340
-
Factors associated with the workload of health professionals in hospital at home: a systematic review
BMC Health Services Research, Vol. 22, Núm. 1
2021
-
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation
Cost Effectiveness and Resource Allocation, Vol. 19, Núm. 1
2019
-
Gender and socioeconomic inequalities in the implementation of the Basque programme for multimorbid patients
European Journal of Public Health, Vol. 29, Núm. 4, pp. 681-686